valine has been researched along with alaproclate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartfai, T; Hedlund, B; Lindberg, UH; Ogren, SO | 1 |
| Hu, PS; Ross, SB | 1 |
2 other study(ies) available for valine and alaproclate
| Article | Year |
|---|---|
GEA 857, a putative blocker of potassium conductance, enhances muscarinic agonist-evoked responses: dissociation from an action on 5-HT mechanisms.
Topics: Alanine; Animals; Antidepressive Agents; Brain; Male; Motor Activity; Parasympathomimetics; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Selective Serotonin Reuptake Inhibitors; Serotonin; Valine | 1992 |
NMDA receptor-mediated increase in cyclic GMP in the rat cerebellum in vivo is blocked by alaproclate and GEA-857.
Topics: 4-Aminopyridine; Alanine; Animals; Behavior, Animal; Cerebellum; Convulsants; Cyclic GMP; Drug Interactions; Harmaline; Male; N-Methylaspartate; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Seizures; Selective Serotonin Reuptake Inhibitors; Valine | 1997 |